The University of Chicago has been awarded a $550,375 Project Grant from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to conduct research on the role of the transcription factor BATF in regulating natural killer (NK) cell expansion and effector function. The project aims to comprehensively characterize BATF's impact on NK cell maturation, anti-tumor immunity, and the NK cell response to viral infection. The research intends to provide insights into manipulating BATF or its target genes for therapeutic interventions against viral diseases and cancer. The grant period runs from February 1, 2025 to January 31, 2030.
Generated 3/4/25, 2:42 AM